Autosomal Dominant Optic Atrophy
📧 Sign up to get email alerts when something new happens for Autosomal Dominant Optic Atrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Safety of Single and Repeat Dose of PYC-001 Eye Injections in People With Autosomal Dominant Optic Atrophy (Myrtle) [Phase 1, Phase 2]
This clinical trial update notes ongoing Phase 1/2 safety testing of a single and repeat dose of PYC-001 eye injections in people with Autos…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: SAD of IVT PYC-001 in OPA1 Mutation-Associated Autosomal Dominant Optic Atrophy (Sundew) [Phase 1]
Phase 1 single-ascending-dose trial of IVT PYC-001 in OPA1 mutation-associated autosomal dominant optic atrophy; the trial is currently acti…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation
Status update on a natural history study of Autosomal Dominant Optic Atrophy due to OPA1 mutation; the trial is terminated.
-
CLINICAL_TRIALS trial_result · 2012-05-04Clinical Trial Update: Transcorneal Electrical Stimulation Therapy for Retinal Disease [NA]
Okuvision GmbH's transcorneal electrical stimulation therapy trial for retinal diseases has completed. Conditions studied include retinitis …